Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [T3] Singh - [177Lu]Lu-DOTA-TATE as First-line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): the NETTER-2 Study Published in 2021 Listed under Poster Download [T2] Lagast - Dose Selection for Paltusotine, a Once Daily Oral Nonpeptide, Somatostatin Receptor 2 Ligand, for the Treatment of Patients with Carcinoid Syndrome (CS) Published in 2021 Listed under Poster Download [T1] El-Rayes - Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects with Advanced Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P9] Mulvey - The Impact of Sociodemographic Factors on Overall Survival for Patients with Adrenocortical Carcinomas in California Published in 2021 Listed under Poster Download [P8] Harsha Tella - Association Between Hospital Volume and Overall Survival of Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P7] Lee - Prevalence and Presentation of Cushing and Carcinoid Syndromes in Patients with Non-metastatic Primary Lung Published in 2021 Listed under Poster Download [P6] Zarate Rodriguez - Surgical Interventions in Patients with Pancreatic Neuroendocrine Tumors: a SEER-based Survival Analysis Published in 2021 Listed under Poster Download [P5] Zarate Rodriguez - Race is an Independent Predictor for Surgery Offer in Patients with Small Bowel Neuroendocrine Tumors But Not Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P4] Poster - Dureja - Think NENs Global Educational Program on Neuroendocrine Neoplasms Diagnostics and Management for Primary Care Physicians Published in 2024 Listed under P, Poster Download [P4] Bateni - Secondary Primary Cancers and Survival among Neuroendocrine Tumor Patients Published in 2021 Listed under Poster Download [P3] Poster - Dalton - Sexual dimorphism in Small Intestinal NETS: Any association with development of mesenteric metastases? Published in 2024 Listed under Poster Download [P3] Bateni - Incidence and Predictors of Second Cancers in Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P2] Poster - Gangi - Novel pathogenic germline variants (PGV) identified in pancreatic neuroendocrine neoplasm (PNEN) patients during genetic testing Published in 2024 Listed under P, Poster Download [P2] Hallet - Incidence of Psychiatric Illness in Patients With Neuroendocrine Tumors - A Comparative Population-Based Published in 2021 Listed under Poster Download [P1] Wong - Predictors And Outcomes Of Minimally Invasive Surgery For Small Bowel Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P1] Poster - Antwi - Rare germline variants in MEN1, TSC1, ATM, and MSH2 are associated with higher risk for pancreatic neuroendocrine tumors Published in 2024 Listed under P, Poster Download [P13] Poster - Fung - Role of genetic alterations and tumour functionality in predicting peptide receptor radionuclide therapy effectiveness and survival in pancreatic neuroendocrine neoplasm Published in 2024 Listed under P, Poster Download [P12] Poster - Mailman - US NETs Clinical Trial Searches as Compared to SEER Prevalence Data from 2011-2021 Indicates Potential Areas of Unmet Needs Published in 2024 Listed under P, Poster Download [P12] Albor - MDT Experience in Argentina in Nets in Times of the Covid19 Pandemic Published in 2021 Listed under Poster Download [P11] Poster - Tan - Re-examining NCTN Clinical Trials for Sex Differences in Outcomes and Toxicities in Patients with Neuroendocrine Neoplasms Published in 2024 Listed under P, Poster Download [P11] Abdelrahman - The Epidemiology of Mixed Acinar Neuroendocrine Carcinoma of the Pancreas in the United States Published in 2021 Listed under Poster Download [P10] Rakshit - Covid-19 in Patients with Neuroendocrine Tumors (NETs): the Mayo Clinic Experience Published in 2021 Listed under Poster Download [O8] Anaka - Understanding Neuroendocrine Tumour Patient Preferences for Medical Management of Midgut NETs Using Discrete Choice Experiments: a DIRECT NETs Study Published in 2021 Listed under Poster Download [O7] Wachtel - Succinate Dehydrogenase Pathogenic Variants are Not Associated with Non-canonical Cancers Published in 2021 Listed under Poster Download [O6] Tsang - Evaluating the Association Between Family History and Overall Survival Among Patients with Gastrointestinal and Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [O5] Poster - Gujarathi - Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the treatment of Metastatic Pancreatic Neuroendocrine Tumors Published in 2024 Listed under O, Poster Download [O5] Hickman - Outcomes of Initial Treatment in Early Stage Neuroendocrine Carcinoma of the Uterine Cervix (NCUC) Published in 2021 Listed under Poster Download [O4] Poster - Gujarathi - MEN1 / DAXX alterations are associated with improved overall survival and treatment response in patients with pancreatic neuroendocrine tumors Published in 2024 Listed under O, Poster Download [O4] Kolarova - Neuroendocrine Tumor Treatments and Follow-up Disease Management - Comparative Perspective (U.S. and Canada Published in 2021 Listed under Poster Download [O3] Poster - Baskar - Racial Disparities in End - Of - Life Care Among Patients with Neuroendocrine Tumors Published in 2024 Listed under Other, Poster Download [O3] Hallet - Patient-reported Cognitive and Psychological Screening in Neuroendocrine Tumors (NETs) - a Prospective Cohort Published in 2021 Listed under Poster Download [O2] Yen - The Feasibility and Acceptability of Health and Wellness Coaching for Neuroendocrine Tumor Patients and Their Published in 2021 Listed under Poster Download [O1] Poster - Hall - Hereditary and Clinical Insights into Paraganglioma and Pheochromocytoma Published in 2024 Listed under Other, Poster Download [O1] Das - A Systematic Survey of Two Decades of Clinical Trials in Neuroendocrine Neoplasms (NENs) Published in 2021 Listed under Poster Download [O11] Poster - Laffan - Health - related quality of life issues in patients with non - metastatic neuroendocrine neoplasms persist after treatment Published in 2024 Listed under O, Poster Download [C9] Siddiqui - Real World Use of Lanreotide in Management of Neuroendocrine Tumours Published in 2021 Listed under Poster Download [C9] Poster - Halfdanarson - Cabozantinib Versus Placebo for Advanced Neuroendocrine Tumors after Progression on Prior Therapy (CABINET Trial/Alliance A021602) Published in 2024 Listed under Clinical, Poster Download [C8] Reidy-Lagunes - Lanreotide Autogel/Depot (LAN) in Patients with Advanced Bronchopulmonary (BP) Neuroendocrine Tumors (NETs): Results From the Phase 3 SPINET Study Published in 2021 Listed under Poster Download [C8] Poster - Mosalem - Temozolomide Induced Hypermutation in Pancreatic Neuroendocrine Tumors: A Case Series Published in 2024 Listed under Clinical, Poster Download [C7] Poster - Schnell - Cabozantinib therapy in patients with previously treated well differentiated grade 3 neuroendocrine tumors (G3 NETs) Published in 2024 Listed under Clinical, Poster Download [C7] Halperin - The Safety and Efficacy of PEN-221 Somatostatin Analog (SSA)-DM1 Conjugate in Patients (Pts) with Advanced GI Mid-gut Neuroendocrine Tumor (NET): Phase 2 Results Published in 2021 Listed under Poster Download [C6] Poster - Young - Evaluation of Switching SSAs on GI - NET Progression: Experience at an Academic Medical Cente Published in 2024 Listed under Clinical, Poster Download [C6] Guo - Impact of Capecitabine and Temozolomide on the Primary Tumor in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C5] Li - Interim analysis results of surufatinib in US patients with neuroendocrine tumors (NETs) Published in 2021 Listed under Poster Download [C57] Chauhan - HPG80 (circulating progastrin), a Novel Blood-based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Published in 2021 Listed under Poster Download [C56] DiPeri - Comparison of Patients with Small Bowel Neuroendocrine Tumor Liver Metastaseswith and without Carcinoid Syndrome: A Single Institutional Analysis Published in 2021 Listed under Poster Download [C55] Pulvirenti - Early Onset Well Differentiated Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathologic Features, and Published in 2021 Listed under Poster Download [C54] Herring - Differences in the Mutation of DAXX, ATRX, and MENIN in Pancreatic Neuroendocrine Tumors from Black and White Published in 2021 Listed under Poster Download [C53] Pommier - A Prospective Study of Carcinoid Crisis with No Perioperative Octreotide Published in 2021 Listed under Poster Download [C52] Nguyen - Role of Chromogranin A in the Diagnosis and Follow up of Neuroendocrine Neoplasms: Real World Review Published in 2021 Listed under Poster Download [C51] Naaseh - A Single-Center Experience in Observation of Small Pancreatic Neuroendocrine Tumors: To Operate or Not to Published in 2021 Listed under Poster Download [C50] Slattery - Detection Method and Overall Survival in Surgically Resected Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C4] Poster - Koch - Comparison of Survival Outcomes and Hypoglycemic Control in Patients Receiving Systemic Therapy for Malignant Insulinoma Published in 2024 Listed under Clinical, Poster Download [C49] Poster - Su - National Trends in Surgical Management of T1N0 Well - Differentiated Pancreatic Neuroendocrine Tumors (PNET) and Age Specific Survival Published in 2024 Listed under Clinical, Poster Download [C49] Watanabe - Importance of Grade in the Surgical Management of Rectal Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C48] Shi - Venous Invasion in Resected Pancreatic Neuroendocrine Tumors Is Independently Associated with Disease Free Published in 2021 Listed under Poster Download [C48] Poster - Collier - Impact of Hospital Type and Location on Survival Outcomes for Patients with Well - Differentiated Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C47] Shi - Pathologic Features of Small Pancreatic Neuroendocrine Tumors with Liver Metastasis Published in 2021 Listed under Poster Download [C47] Poster - Slaby - Response After Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C46] Gudmundsdottir - Alternative Lengthening of Telomeres Is Associated with Aggressive Pathologic Features and Increased Recurrence Risk in Large Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C45] Tran - Management of Duodenal Neuroendocrine Tumors: Surgical Versus Endoscopic Mucosal Resection Published in 2021 Listed under Poster Download [C45] Poster - Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes Published in 2024 Listed under Clinical, Poster Download [C44] Gudmundsdottir - Multifocality Is Not Associated with Worse Survival in Sporadic Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C43] Poster - Wornow - To Treat or Not to Treat: Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2024 Listed under Clinical, Poster Download [C43] Malhotra - MRI Has Improved Detection of Small Neuroendocrine Liver Metastasis Compared with Ga-68 DOTATATE Published in 2021 Listed under Poster Download [C42] Zan - A Case of G3-WD Gastric Carcinoid Tumor in a MEN1 Patient with Discrepant Treatment Response to PRRT in Published in 2021 Listed under Poster Download [C42] Poster - Evans - Loss of MGMT Protein Expression by Immunohistochemistry is Associated with Response to Capecitabine/Temozolomide in Neuroendocrine Neoplasms (NENs) Published in 2024 Listed under Clinical, Poster Download [C41] Poster - Yogo - Long-term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C41] Gupta - Concurrent Everolimus with Hepatic Transarterial Bland Embolotherapy [Evero-Embo] in Patients with Bulky and/or Progressive Metastatic Well Differentiated Neuroendocrine Published in 2021 Listed under Poster Download [C40] Gococo-Benore - Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients Published in 2021 Listed under Poster Download [C3] Li - Patient-reported Clinical and Productivity Outcomes From the Longitudinal Telotristat Ethyl Treatment Registry Published in 2021 Listed under Poster Download [C39] Bodei - Blood-based Genomic Assessment of Clinical Efficacy and Toxicity of 177Lu-DOTATATE of Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C38] Poster - Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C38] Lawhn-Heath - Clinical Utility of Qualitative Post-treatment SPECT After Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download [C37] Coffman - Treatment Response and Clinical Outcomes of Well-differentiated (WD) High-grade (HG) Neuroendocrine Tumors (NETs) to 177Lu-DOTATATE Published in 2021 Listed under Poster Download [C36] Soulen - Cap-Tem-Y90 for Grade 2 Liver-dominant Net Metastases Published in 2021 Listed under Poster Download [C35] Poster - Jacques - Small bowel obstruction incidence in Lu177 PRRT patients had no impact on overall survival Published in 2024 Listed under Clinical, Poster Download [C35] Manohar - 177Lu Dotatate Peptide Receptor Radionuclide Therapy in Chronic Kidney Disease Patients: a Single Center Experience Published in 2021 Listed under Poster Download [C34] Pryma - Secondary Hematological Malignancies Following Highspecific Activity Iodine-131 Metaiodobenzylguanidine Treatment of Advanced Pheochromocytoma and Published in 2021 Listed under Poster Download [C34] Poster - Tuchayi - Peptide Receptor Radionuclide Therapy with 177 Lu - DOTATATE: A Single Center Experience Published in 2024 Listed under Clinical, Poster Download [C33] Norman - Utility of Midpoint Imaging in Patients Receiving Peptide Receptor Radionuclide Therapy (PRRT) for Advance Progressive Gastroenteropancreatic-Neuroendocrine Published in 2021 Listed under Poster Download [C32] Kunz - The Phase 3 NETTER-1 Study of 177Lu-DOTATATE in Patients with Midgut Neuroendocrine Tumors: Updated Published in 2021 Listed under Poster Download [C31] Grønbæk - Safety and Effectiveness of 177Lu-Satoreotide Tetraxetan in Patients with Progressive Neuroendocrine Tumors (NETs): Interim Analysis of a Phase I/II Study Published in 2021 Listed under Poster Download [C30] Halfdanarson - Compose: Pivotal Phase III Trial of 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade 2 and Grade 3 Gastroenteropancreatic Published in 2021 Listed under Poster Download [C2] Mohamed - The Role of Microbiome in Gastroentero-pancreatic Neuroendocrine Neoplasms (GEP-NENs) Published in 2021 Listed under Poster Download [C29] Poster - D'Souza - Integrating Yttrium - 90 Radioembolization with Capecitabine - Temozolomide for Grade 3 Liver - Dominant Metastatic Neuroendocrine Tumors: Initial Outcomes Published in 2024 Listed under Clinical, Poster Download [C29] Clement - Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Advanced Pancreatic Neuroendocrine Tumours (panNETs): Data From the NETTER-R International, Published in 2021 Listed under Poster Download [C28] Yu - Subgroup Analysis by Ki-67 and Baseline CgA of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Pancreatic Published in 2021 Listed under Poster Download [C28] Poster - Zhou - Liver - directed therapy for metastatic neuroendocrine carcinoma and grade 3 well - differentiated neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C27] Zhou - Subgroup Analysis by Ki-67 and Primary Tumor Origins of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Extrapancreatic Neuroendocrine Tumors (SANET-ep) Published in 2021 Listed under Poster Download [C27] Poster - Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Grade 2/3 Well - Differentiated Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C26] Duan - Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Published in 2021 Listed under Poster Download [C25] Weekley - Comparing Periprocedural Hemodynamic Instability in Y-90 Radioembolization and Bland Embolization for Neuroendocrine Tumor Liver Metastases Published in 2021 Listed under Poster Download [C25] Poster - O'Leary - Associations between patterns of neuroendocrine liver metastatic burden and outcomes after embolization, CapTem and PRRT Published in 2024 Listed under Clinical, Poster Download [C24] Badawy - Peptide Receptor Radionuclide Therapy (Lu-177 DOTATATE) in Progressive Neuroendocrine Tumors (NETs): Potential Predictors of Progression Free Survival (PFS) Published in 2021 Listed under Poster Download [C23] Wong - Long-term Outcomes Following 90YRadioembolization of Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C23] Poster - Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C22] Poster - Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C22] Attiyeh - Defining MRI Superiority Over CT for Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C21] Das - Validation of a Clinical Score (CS) for Patients With WellDifferentiated Neuroendocrine Tumors (WD NETs) Under Consideration for Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download Select the number of documents per page 5 10 15 20 25 30 50 100 «12345»
